TY - JOUR
T1 - Effects of family history and apolipoprotein E ε4 status on cognitive decline in the absence of Alzheimer dementia
T2 - The cache county study
AU - Hayden, Kathleen M.
AU - Zandi, Peter P.
AU - West, Nancy A.
AU - Tschanz, Joann T.
AU - Norton, Maria C.
AU - Corcoran, Chris
AU - Breitner, John C.S.
AU - Welsh-Bohmer, Kathleen A.
PY - 2009/11
Y1 - 2009/11
N2 - Objective: To evaluate the influences of a family history of Alzheimer dementia (FHxAD) and the apolipoprotein E ε4 genotype (APOE ε4) on cognitive decline. Design, Setting, and Participants: Residents of Cache County, Utah, aged 65 years or older, were invited to participate. At baseline, 2957 participants provided DNA for genotyping of APOE and a detailed FHxAD. They also completed the Modified Mini-Mental State Examination. Cognitive status was reexamined after 3 and 7 years. We used mixed-effects models to examine the association among FHxAD, APOE ε4, and cognitive trajectories. Main Outcome Measure: Modified Mini-Mental State Examination score trajectories over time. Results: Compared with participants who did not have APOE ε4 or an FHxAD, those with APOE ε4 scored lower on the Modified Mini-Mental State Examination at baseline (-0.70 points; 95% confidence interval [CI], -1.15 to -0.24). Participants with an FHxAD and APOE ε4 differed less, if at all, in baseline score (-0.46 points; 95% CI, -1.09 to 0.16) but declined faster during the 7-year study (-9.75 points [95% CI, -10.82 to -8.67] vs -2.91 points [95% CI, -3.37 to -2.44]). After exclusion of participants who developed prodromal AD or incident dementia, the group with an FHxAD and APOE ε4 declined much less during the 7-year study (-1.54; 95% CI, -2.59 to -0.50). Conclusions: Much of the association among FHxAD, APOE ε4, and cognitive decline may be attributed to undetected incipient (latent) disease. In the absence of latent disease, the 2 factors do not appear individually to be associated with cognitive decline, although they may be additive.
AB - Objective: To evaluate the influences of a family history of Alzheimer dementia (FHxAD) and the apolipoprotein E ε4 genotype (APOE ε4) on cognitive decline. Design, Setting, and Participants: Residents of Cache County, Utah, aged 65 years or older, were invited to participate. At baseline, 2957 participants provided DNA for genotyping of APOE and a detailed FHxAD. They also completed the Modified Mini-Mental State Examination. Cognitive status was reexamined after 3 and 7 years. We used mixed-effects models to examine the association among FHxAD, APOE ε4, and cognitive trajectories. Main Outcome Measure: Modified Mini-Mental State Examination score trajectories over time. Results: Compared with participants who did not have APOE ε4 or an FHxAD, those with APOE ε4 scored lower on the Modified Mini-Mental State Examination at baseline (-0.70 points; 95% confidence interval [CI], -1.15 to -0.24). Participants with an FHxAD and APOE ε4 differed less, if at all, in baseline score (-0.46 points; 95% CI, -1.09 to 0.16) but declined faster during the 7-year study (-9.75 points [95% CI, -10.82 to -8.67] vs -2.91 points [95% CI, -3.37 to -2.44]). After exclusion of participants who developed prodromal AD or incident dementia, the group with an FHxAD and APOE ε4 declined much less during the 7-year study (-1.54; 95% CI, -2.59 to -0.50). Conclusions: Much of the association among FHxAD, APOE ε4, and cognitive decline may be attributed to undetected incipient (latent) disease. In the absence of latent disease, the 2 factors do not appear individually to be associated with cognitive decline, although they may be additive.
UR - http://www.scopus.com/inward/record.url?scp=70449635820&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70449635820&partnerID=8YFLogxK
U2 - 10.1001/archneurol.2009.237
DO - 10.1001/archneurol.2009.237
M3 - Article
C2 - 19901170
AN - SCOPUS:70449635820
SN - 0003-9942
VL - 66
SP - 1378
EP - 1383
JO - Archives of neurology
JF - Archives of neurology
IS - 11
ER -